M
IMEPro
G89.0 Pain
Updated March 2026

Central pain syndrome

ICD-10 Code: G89.0 · Body Part: Head/Brain (TBI)

QME Evaluation Process

Neurological examination, pain assessment, functional evaluation. Typically post-stroke or post-TBI. Rate per underlying neurological condition plus pain add-on.

Typical Impairment Rating

Varies based on underlying condition; pain add-on up to 3% WPI

AMA Guides Edition

5th Edition

Common Treatments

+ Antiepileptic medications
+ Antidepressants
+ Pain management
+ Cognitive behavioral therapy

Related Conditions

Body Part Guide

Head/Brain (TBI) Evaluation Guide

Impairment rating methods, common conditions, and QME evaluation protocols

View Guide →

QME Specialties for Central pain syndrome

Find a QME Specialist

Browse QME-certified physicians who evaluate central pain syndrome and related head/brain (tbi) conditions in California.

Browse Neurology Physicians →

Frequently Asked Questions

What is Central pain syndrome (G89.0)?

Central pain syndrome is an ICD-10 diagnosis code (G89.0) classified under Pain conditions. It affects the Head/Brain (TBI) and is occasionally seen in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.

How is G89.0 rated for impairment?

The typical whole person impairment (WPI) range for Central pain syndrome is Varies based on underlying condition; pain add-on up to 3% WPI. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.

What is the QME evaluation process for G89.0?

Neurological examination, pain assessment, functional evaluation. Typically post-stroke or post-TBI. Rate per underlying neurological condition plus pain add-on.

What treatments are common for Central pain syndrome?

Common treatments for Central pain syndrome include Antiepileptic medications, Antidepressants, Pain management, Cognitive behavioral therapy. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.